| Q71814762 | 18FDG PET and acetazolamide-enhanced99mTc-HMPAO SPET in systemic lupus erythematosus |
| Q57450789 | Acute psychosis presenting in a patient with systemic lupus erythematosus: Answers |
| Q52026140 | Alterations of cerebral glucose metabolism indicate progress to severe morphological brain lesions in neuropsychiatric systemic lupus erythematosus. |
| Q71775354 | Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus |
| Q48465933 | Association of global brain damage and clinical functioning in neuropsychiatric systemic lupus erythematosus |
| Q34307190 | Brain single-photon emission tomography with 99mTc-HMPAO in neuropsychiatric systemic lupus erythematosus: relations with EEG and MRI findings and clinical manifestations |
| Q48280020 | CNS lupus--where do we go from here? |
| Q56552806 | Callosal holes: an unusual imaging appearance in systemic lupus erythematosus. A case report |
| Q48280000 | Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations |
| Q37364835 | Cerebral Small Vessel Disease Burden Is Increased in Systemic Lupus Erythematosus |
| Q48491099 | Cerebral magnetic resonance imaging in patients with or without antiphospholipid antibodies |
| Q50702607 | Cognitive impairment and antiphospholipid syndrome: is paradoxical embolism the rule? |
| Q35549279 | Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET |
| Q74385636 | Diffusion-weighted echo-planar MR imaging of CNS involvement in systemic lupus erythematosus |
| Q31933342 | Evaluation of patients with CNS involvement in SLE. |
| Q31942717 | Internuclear ophthalmoplegia in systemic lupus erythematosus |
| Q51823798 | Localization of cerebral functional deficits in patients with non-neuropsychiatric systemic lupus erythematosus. |
| Q31140232 | Magnetic resonance imaging in the evaluation of central nervous system manifestations in systemic lupus erythematosus |
| Q53414080 | Multiple brain calcifications in a patient with systemic lupus erythematosus. |
| Q48391957 | Neurodegeneration in autoimmune MRL-lpr mice as revealed by Fluoro Jade B staining. |
| Q33753228 | Neuroimaging in neuropsychiatric systemic lupus erythematosus |
| Q40149699 | Neurometabolic changes in normal white matter may predict appearance of hyperintense lesions in systemic lupus erythematosus |
| Q36915630 | Neuropsychiatric involvement in pediatric systemic lupus erythematosus |
| Q71933430 | Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests |
| Q44996535 | Pattern of neuropsychiatric manifestations and outcome in juvenile systemic lupus erythematosus |
| Q33292539 | Posterior reversible encephalopathy syndrome: another manifestation of CNS SLE? |
| Q73251573 | Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus |
| Q35555754 | Proton magnetic resonance spectroscopy may predict future brain lesions in SLE patients: a functional multi-imaging approach and follow up. |
| Q34321259 | Psychosis in a young female – a diagnostic and therapeutic challenge |
| Q30887271 | Quantitative magnetic resonance imaging in neuropsychiatric systemic lupus erythematosus. |
| Q81020603 | Recurrent headache and MRI findings in systemic lupus erythematosus |
| Q48249217 | Reversal of brain dysfunction with UV-A1 irradiation in a patient with systemic lupus |
| Q28345781 | Sensitivity of quantitative (1)H magnetic resonance spectroscopy of the brain in detecting early neuronal damage in systemic lupus erythematosus |
| Q48663139 | Serial single photon emission computed tomography imaging in patients with cerebral lupus during acute exacerbation and after treatment. |
| Q57647177 | Silent cerebral MRI findings in lupus nephritis patients: Is it clinically significant? |
| Q52020365 | Subdural fluid collections: an unusual manifestation of CNS disease in a connective tissue disorder. |
| Q35625216 | The ACR nomenclature for CNS lupus revisited. |
| Q33329947 | Thrombocytopenic thrombotic purpura: severe clinic with no CT, minor MRI, but a SPECT correlate |
| Q41490850 | Unusual F-18 FDG Uptake at the Ears of a Patient with Discoid Lupus Erythematosus Diskoid Lupus Eritamatozus |
| Q33195490 | Value of MRI of the brain in patients with systemic lupus erythematosus and neurologic disturbance |
| Q75310693 | [MRI of central nervous system in a series of 58 systemic lupus erythematosus (SLE) patients with or without overt neuropsychiatric manifestations] |